IL-2 MESSENGER-RNA EXPRESSION IN TAC-POSITIVE MALIGNANT-LYMPHOMAS
- 1 February 1990
- journal article
- research article
- Vol. 136 (2) , 383-390
Abstract
Expression of the IL-2 receptor (Tac antigen/CD25) is documented in malignant lymphomas. Because IL-2 is a major lymphocyte growth factor, an IL-2-dependent growth could be involved in the proliferation of Tac-positive lymphomas. Indeed such a mechanism has been demonstrated experimentally for the growth of T-cell lines. To investigate this point in human lymphomas, we used in situ hybridization to analyze the expression of the IL-2 gene in 20 non-Hodgkin''s lymphomas, among which 12 expressed the IL-2 receptor. Nine of these were anaplastic large cell lymphomas expressing the Ki-1-related antigen. We here show that IL-2-producing cells are present in all the lymphomas we analyzed. As a mean, there is no significant difference in the percentage of IL-2-producing cells between Tac-positive and- negative lymphomas. However, the level of IL-2 production is highly heterogenous in both groups, and the highest density of IL-2-producing cells was observed in 2 Tac-positive lymphomas. Simultaneous detection of cellular antigens and of IL-2 mRNA demonstrates that IL-2 is produced by reactive T cells rather than by tumor cells. These results suggest that if IL-2 is involved in the growth of Tac-positive lymphomas, it acts as a paracrine, rather than an autocrine, factor.This publication has 35 references indexed in Scilit:
- Visualizing interleukin 2 gene expression at the single cell levelEuropean Journal of Immunology, 1989
- Interleukin-2 Receptor β Chain Gene: Generation of Three Receptor Forms by Cloned Human α and β Chain cDNA'sScience, 1989
- Autocrine growth and tumorigenicity of interleukin 2-dependent helper T cells transfected with IL-2 gene.The Journal of Experimental Medicine, 1989
- In situ hybridization for interleukin 2 and interleukin 2 receptor mRNA in T cells activated in the presence or absence of cyclosporin A.The Journal of Experimental Medicine, 1988
- Ki-1 Positive Large Cell LymphomaThe American Journal of Surgical Pathology, 1988
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Retroviral activation of interleukin 2 gene in a gibbon ape T cell lymphoma line.The Journal of Experimental Medicine, 1986
- The Structure, Function, and Expression of Interleukin-2 Receptors on Normal and Malignant LymphocytesScience, 1986
- T-Cell Growth Factor Gene: Lack of Expression in Human T-Cell Leukemia-Lymphoma Virus-Infected CellsScience, 1984
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982